First patient treated in new phase II clinical trial at Radiumhospitalet in Oslo – promising use of Lytix cancer treatment in patients with early-stage melanoma November 6, 2024
Mårten Frostne, CEO of FlexQube AB (publ), has decided to leave his role to pursue new challenges outside the company. November 6, 2024